Cardiovascular
Cardiovascular Systems, one of the most attractive medtech M&A targets, develops this orbital atherectomy system, which is
CardiovascularAbbott Nabs a 'Most Attractive' Target as Medtech M&A SwellsAbbott Nabs a 'Most Attractive' Target as Medtech M&A Swells
Big medtech unleashed a flurry of M&A activity this week, with Abbott and GE HealthCare among the big spenders.
Sign up for the QMED & MD+DI Daily newsletter.